News from the FDA/CDC
News from the FDA/CDC
CDC panel: Pause of J&J COVID-19 vaccine to remain for now
“Putting this vaccine on pause for those of us that are frontline health care workers has really been devastating.”
FDA/CDC
List of COVID-19 high-risk comorbidities expanded
Underlying conditions increase the risk of severe outcomes for patients infected with SARS-CoV-2.
News from the FDA/CDC
COVID-19 in 2020: Deaths and disparities
FDA/CDC
CDC adds new medical conditions to COVID-19 high-risk list
...
News from the FDA/CDC
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
News from the FDA/CDC
Black nonsmokers still at high risk for secondhand smoke exposure
The prevalence of SHS exposure among nonsmokers declined from 87.5% to 25.3% between 1988 and 2012.
News from the FDA/CDC
CDC data strengthen link between obesity and severe COVID
Progressively intensive management of COVID-19 might be needed for patients with more severe obesity.
FDA/CDC
FDA authorizes first molecular at-home, OTC COVID-19 test
The Cue OTC Test is the first molecular diagnostic test available to consumers without a prescription.
News from the FDA/CDC
U.S. suicide rate in 2019 took first downturn in 14 years
As the response to the COVID-19 pandemic continues, the investigators pointed out, "prevention is more important than ever."
News from the FDA/CDC
J&J COVID-19 vaccine wins unanimous backing of FDA panel
The Johnson & Johnson vaccine is expected to offer more convenient dosing and be easier to distribute than the two rival products already...
News from the FDA/CDC
Variants spur new FDA guidance on COVID vaccines, tests, drugs
The FDA has already been communicating with individual manufacturers as they assess the variants’ effect on their products.